Healthcare Providers Increase their Efficacy in Photodynamic Therapy for Breast Cancer Resistance

New discoveries in photodynamic therapy (PDT) are benefitting cancer patients. As such, it has been found that, PDT is effective in treating multidrug-resistant breast cancer. Dysfunctional DNA repair genes and abnormal signal transduction are some of the major complications associated with breast cancer resistance. Hence, companies in the photodynamic therapy market are becoming increasingly aware about the complications of breast cancer resistance, and increasing the availability of PDT in hospitals and cancer treatment centers.

Cancer is projected to account for the highest revenue amongst all applications in the photodynamic therapy market, with an estimated value of ~US$ 2.3 billion by the end of 2023. This is why, healthcare companies are increasing awareness about PDT amongst breast cancer resistant patients. As such, PDT is being used as an alternative to broad-spectrum antibiotics-based therapy, thus minimizing the incidence of drug resistance. Companies are also increasing R&D to assess PDT-resistant cells to further study the impact of PDT on cellular targets. Healthcare providers are increasing their efficacy in PDT technology to achieve therapeutic relevance in appropriate photosensitizer (PS) level with its retention in the target tissue.

photodynamic therapy market infographic

To know the scope of our report Get a Sample on Photodynamic Therapy Market

Dermoscopy Aids in Assessment of ALA Drugs Effective for AK Treatment

Growing incidence of actinic keratosis (AK) have led to innovations in the photodynamic therapy market. Dermoscopy serves as a useful tool for monitoring skin lesions during PDT and follow-up. Healthcare providers in the photodynamic therapy landscape are treating actinic keratosis (AK) patients with aminolevulinic acid (ALA) drugs. ALA agents are increasingly gaining popularity, and are anticipated to account for the highest revenue amongst all drugs in the photodynamic therapy market, with a projected value of ~US$ 4 billion by the end of 2027. Thus, healthcare providers in hospitals and dermatology clinics are offering topical ALA-PDT, since the treatment is widely approved by health commissions across various countries.

Dermoscopic monitoring is being used in tandem with PDT, and serves as a valuable and non-invasive technique, not just for diagnosing AK but also other serious skin diseases. The technique of dermoscopy is very useful for healthcare providers, since it can visualize the morphological structures of the inner layers of the skin that are not visible to the naked eye. Thus, dermoscopy is boosting the growth of the photodynamic therapy market.

Get a glimpse of the in-depth analysis through our Report Brochure

Customized Protocol Strategies Deliver Enhanced Clinical Translation

Healthcare providers in the photodynamic therapy market are adopting new strategies to achieve enhanced clinical translation. They are using the approach of customized protocols for the treatment of cancer and other infectious diseases. Companies are developing improved formulations of porphyrin-derivative (PD) compounds. This trend is projected to grow during the forecast period, since PD is projected to account for the second-highest revenue amongst all drugs in the photodynamic therapy market, with an estimated value of ~US$ 3 billion by the end of 2027. Hence, companies are developing intelligent PD molecules that can target specific cells and offer efficient drug delivery.

Companies in the photodynamic therapy market are developing strategies to improve transdermal ALA delivery. They are utilizing high-power CO2 lasers to produce microhole grating. Companies are increasing the production of ALA creams, since the grating procedure is followed by the application of the cream, assisted by ultrasound, to enhance the cream’s penetration into the holes. Another approach, such as the use of a soluble microneedle patch, helps in continuous delivery of ALA until the material is completely dissolved inside the lesion.

Innovative Photodynamic Devices Show the Way for Exponential Growth in Cancer Treatment

The photodynamic therapy and light-based therapy market are maturing at a rapid pace. However, prevailing challenges catering to the delivery of light to the right body part with adequate strength and specificity are likely to impede market growth. Another challenge is that, the photodynamic therapy market is highly consolidated, with only three market players accounting for ~90% of the market share. This makes it challenging for medium- and small-scale players to compete with these major players in the landscape.

In order to overcome the challenges of light delivery, companies are increasing their production capabilities to improve the efficacy of novel delivery systems in photodynamic therapy. To achieve the intended therapeutic effect on the target, small- and medium-scale players are increasing R&D to develop wirelessly-powered light-emitting devices that improve the specificity of light-based cancer therapy. Innovations in devices have facilitated the treatment for hard-to-detect microtumors and deeply-located lesions. Photodynamic devices are increasingly meeting the needs of cancer patients due to the availability of devices that do not require surgical suturing.

photodynamic therapy market segmentation

Expanding operations in future? To get the perfect launch ask for a custom report

Analysts’ Viewpoint

Phosistos protocol involving new light-emitting devices are gaining popularity for the effective treatment of actinic keratosis. Companies in the photodynamic therapy market are also gaining a strong hold though inorganic strategies such as label extensions. For instance, in September 2019, Biofrontera - a leading biopharmaceutical company, announced label extension for Ameluz(R)  - an ALA used for the treatment of mild and moderate actinic keratosis in PDT.

However, prevalent challenges in drug-resistant breast cancer treatment, such as blood vessel occlusion, collapse, and ultimate vascular shutdown, pose as a challenge in PDT. Thus, companies should increase research efforts to evaluate the advantages of photochemical internalization to facilitate the cytosolic delivery of macromolecular drugs to combat multidrug-resistant breast cancer.

Global Photodynamic Therapy Market: Overview

  • This report analyzes the current scenario and future growth prospects of the global photodynamic therapy market. High prevalence and increase in the incidence of cancer, increase in the number of clinical trials, and rapidly growing bio-pharmaceutical industry are key factors that are projected to drive the global photodynamic therapy market during the forecast period.
  • An article published by Soligenix (2019) states that, the company has conducted clinical research with SGX301 for the treatment of cutaneous T-cell lymphoma (CTCL). Fluorescent-light-activated synthetic hypericin is undergoing the pivotal Phase-3 trial in the U.S.
  • Photodynamic therapy (PDT) has received clinical approval for use as a minimally-invasive therapeutic procedure, and it has been widely applied in the diagnosis and treatment of malignancies, including lung, esophageal, gastrointestinal, bladder, prostate, head & neck, and oral & skin cancer.
  • Rise in the prevalence of skin disorders and cancer, surge in the demand for minimally-invasive procedures, and increase in economic burden of cancer are anticipated to drive the global photodynamic therapy market during the forecast period.
  • The global photodynamic therapy market was valued at ~US$ 3 Bn in 2018, and is anticipated to reach ~US$ 11.8 Bn by 2027, expanding at a CAGR of ~17% from 2019 to 2027.
  • North America and Europe were major markets for photodynamic therapy in 2018.
  • The photodynamic therapy market in Asia Pacific is expected to expand at a high CAGR of ~18% during the forecast period.

Global Photodynamic Therapy Market: Key Segments

  • In terms of product, the global photodynamic therapy market has been segmented into drugs and devices. The drugs segment has been sub-divided into porphyrin derivative (PD), aminolevulinic acid (ALA), chlorines and others. The porphyrin derivative (PD) segment is further divided into hematoporphyrin derivative (HpD), benzoporphyrin derivative (BPD), texaphyrins, and others. The devices segment is further divided into disposable fiber optic light delivery devices (DFOLDD) and diode laser. The drugs segment accounted for a major market share in 2018.
  • Based on application, the global photodynamic therapy market has been segmented into cancer, actinic keratosis (AK), psoriasis, acne, and others. The cancer segment has been sub-divided into basal cell carcinoma, non-small cell lung cancer, head & neck cancer, and others. The cancer segment held a major share of the global photodynamic therapy market in 2018, and the trend is anticipated to continue during the forecast period.
  • According to the American Society of Clinical Oncology (ASCO), head & neck cancer accounted for nearly 4% of all cancers in the U.S. in 2017. The report indicated that, approximately 65,000 individuals in the country would develop head & neck cancer in 2019.
  • In terms of end user, the global photodynamic therapy market has been classified into hospitals, cosmetics & dermatology clinics, cancer treatment centers, and others. The hospitals segment accounted for a major market share in 2018.
  • Market size and forecast for each of these segments of the global photodynamic therapy market have been provided for the period from 2017 to 2027. The CAGRs of the respective segments have also been provided for the period from 2019 to 2027, considering 2018 as the base year.

Global Photodynamic Therapy Market: Winning Imperatives

Approval of New Biologics for Photodynamic Therapy

  • The approval of new biologics by regulatory authorities in developed as well as developing countries has enabled patients to gain access to new treatment options. A large number of pharmaceutical companies operating in the global photodynamic therapy market have received approval from the Food & Drug Administration (FDA), the European Commission, and China FDA. Some of the major drug approvals are as follows:
    • In May 2016, Biofrotera AG received FDA approval for use of its combination topical prescription drug called Ameluz and medical device called BF-RhodoLED for PDT in the treatment of mild-to-moderate actinic keratosis (AK) on the face and the scalp.
    • In November 2016, Biofrontera AG received approval from the European Commission for Ameluz.

Rapidly Growing Biopharmaceutical Industry in Developing Economies

  • The pharmaceutical industry in developing economies has evolved significantly over the last few years, with increasing focus on research activities by government and private research institutes, growth in efforts toward the development of innovative pharmaceutical solutions, and rising focus on offering cost-effective therapeutic options for the treatment of various ailments.
  • According to a report by India Brand Equity Foundation, the biotechnology industry in India, which comprises bio-pharmaceutical, bio-agriculture, bio-services, and bioinformatics, is likely to expand at an average growth rate of 22% from 2017 to 2025, to reach value of US$ 100 Bn by 2025.

Global Photodynamic Therapy Market: Competition

  • Key players in the global photodynamic therapy market have been profiled based on attributes such as company overview, product portfolio, financial overview, recent developments, and competitive business strategies.
  • Major companies profiled in the global photodynamic therapy market report are -
    • Biofrontera AG
    • Theralase Technologies Inc.
    • Lumibird
    • Quest PharmaTech Inc.
    • Modulight, Inc.
    • Galderma Laboratories L.P. (Nestlé)
    • Sun Pharmaceutical Industries Ltd.
    • SUS Advancing Technology Co., Ltd.
  • In April 2018, Biofrontera AG launched Ameluz in combination with daylight-PDT.
  • In August 2017, Biofrontera AG launched Ameluz and BF-RhodoLED in the market in Israel by partnering with Perrigo.
  • In October 2016, Biofrontera AG launched AMELUZ gel (10%) and BF-RhodoLED lamp in the U.S. market.
  • In January 2015, Modulight, Inc. launched the ML7710 laser platform. The device has various applications such as photoimmunotherapy, photodynamic therapy, surgical, dentistry, photo disinfection, aesthetic, vein treatment, and hyperthermia of tumors.

Global Photodynamic Therapy Market - Segmentation

Product

Drugs

  • Porphyrin Derivative (PD)
    • Hematoporphyrin Derivative (HpD)
    • Benzoporphyrin Derivative (BPD)
    • Texaphyrins
    • Others
  • Aminolevulinic Acid (ALA)
  • Chlorines
  • Others

Devices

  • Disposable Fiber Optic Light Delivery Devices (DFOLDD)
  • Diode Lasers

Application

Cancer

  • Basal Cell Carcinoma
  • Non-small Cell Lung Cancer
  • Head & Neck Cancer
  • Others

Actinic Keratosis (AK)

Psoriasis

Acne

Others

End User

Hospitals

Cosmetics & Dermatology Clinics

Cancer Treatment Centers

Others

Region

North America

Europe

Asia Pacific

Latin America

Middle East & Africa

Frequently Asked Questions

Photodynamic therapy market to reach a value of US$ 11.8 Bn by 2027

Photodynamic therapy market is projected to expand at a CAGR of ~17% from 2019 to 2027

Photodynamic therapy market is driven by increase in the prevalence as well as incidence of cancer and skin diseases

North America accounted for a major share of the global photodynamic therapy market

Key players in the global photodynamic therapy market are Biofrontera AG, Theralase Technologies Inc., Lumibird, Quest PharmaTech Inc., Modulight, Inc., Galderma Laboratories L.P. (Nestlé)

1. Preface 

    1.1. Market Definition and Scope

    1.2. Market Segmentation

    1.3. Key Research Objectives

    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Photodynamic Therapy Market

4. Market Overview

    4.1. Introduction

    4.2. Overview

    4.3. Market Dynamics

        4.3.1. Drivers

        4.3.2. Restraints

        4.3.3. Opportunities

    4.4. Global Photodynamic Therapy Market Analysis and Forecast, 2017–2027

5. Market Outlook

    5.1. Epidemiology of Skin Disorders and Cancer 

    5.2. Major Companies in Global Photodynamic Therapy Market

    5.3. Regulatory Scenario Assessment

    5.4. Technological Advancements

    5.5. Major Diseases Treated through Photodynamic Therapy

    5.6. Patent Landscape Summary

6. Global Photodynamic Therapy Market Value (US$ Mn) Forecast, by Product 

    6.1. Introduction & Definition 

    6.2. Global Photodynamic Therapy Market Value Forecast, by Product, 2017–2027

        6.2.1. Drugs

            6.2.1.1. Porphyrin Derivative (PD)

                6.2.1.1.1. Hematoporphyrin Derivative (HpD)

                6.2.1.1.2. Benzoporphyrin Derivative (BPD)

                6.2.1.1.3. Texaphyrins 

                6.2.1.1.4. Others

            6.2.1.2. Aminolevulinic acid (ALA)

            6.2.1.3. Chlorines

            6.2.1.4. Others

        6.2.2. Devices

            6.2.2.1. Disposable Fiber Optic Light Delivery Devices (DFOLDD)

            6.2.2.2. Diode Laser 

    6.3. Global Photodynamic Therapy Market Attractiveness, by Product

7. Global Photodynamic Therapy Market Value (US$ Mn) Forecast, by Application 

    7.1. Introduction 

    7.2. Global Photodynamic Therapy Market Value Forecast, by Application, 2017–2027

        7.2.1. Cancer

            7.2.1.1. Basal Cell Carcinoma

            7.2.1.2. Non-small Cell Lung Cancer

            7.2.1.3. Head & Neck Cancer

            7.2.1.4. Others

        7.2.2. Actinic Keratosis (AK)

        7.2.3. Psoriasis

        7.2.4. Acne

        7.2.5. Others

    7.3. Global Photodynamic Therapy Market Attractiveness, by Application

8. Global Photodynamic Therapy Market Value (US$ Mn) Forecast, by End-user

    8.1. Introduction 

    8.2. Global Photodynamic Therapy Market Value Forecast, by End-user, 2017–2027

        8.2.1. Hospitals

        8.2.2. Cosmetics & Dermatology Clinics

        8.2.3. Cancer Treatment Centers

        8.2.4. Others 

    8.3. Global Photodynamic Therapy Market Attractiveness, by End-user

9. Global Photodynamic Therapy Market Value (US$ Mn) Forecast, by Region

    9.1. Introduction 

    9.2. Global Photodynamic Therapy Market Value Forecast, by Region, 2017–2027

        9.2.1. North America

        9.2.2. Europe

        9.2.3. Asia Pacific

        9.2.4. Latin America

        9.2.5. Middle East & Africa  

    9.3. Global Photodynamic Therapy Market Attractiveness, by Region

10. North America Photodynamic Therapy Market Analysis and Forecast 

    10.1. Introduction

    10.2. North America Photodynamic Therapy Market Value Forecast, by Product, 2017–2027

        10.2.1. Drugs

            10.2.1.1. Porphyrin Derivative (PD)

                10.2.1.1.1. Hematoporphyrin Derivative (HpD)

                10.2.1.1.2. Benzoporphyrin Derivative (BPD)

                10.2.1.1.3. Texaphyrins 

                10.2.1.1.4. Others

            10.2.1.2. Aminolevulinic Acid (ALA)

            10.2.1.3. Chlorines

            10.2.1.4. Others

        10.2.2. Devices

            10.2.2.1. Disposable Fiber Optic Light Delivery Devices (DFOLDD)

            10.2.2.2. Diode Laser 

    10.3. North America Photodynamic Therapy Market Value Forecast, by Application, 2017–2027

        10.3.1. Cancer

            10.3.1.1. Basal Cell Carcinoma

            10.3.1.2. Non-small Cell Lung Cancer

            10.3.1.3. Head & Neck Cancer

            10.3.1.4. Others

        10.3.2. Actinic Keratosis (AK)

        10.3.3. Psoriasis

        10.3.4. Acne

        10.3.5. Others

    10.4. North America Photodynamic Therapy Market Value Forecast, by End-user, 2017–2027

        10.4.1. Hospitals

        10.4.2. Cosmetics & Dermatology Clinics

        10.4.3. Cancer Treatment Centers

        10.4.4. Others 

    10.5. North America Photodynamic Therapy Market Value Forecast, by Country/Sub-region, 2017–2027

        10.5.1. U.S.

        10.5.2. Canada

    10.6. North America Photodynamic Therapy Market Attractiveness Analysis

        10.6.1. By Product

        10.6.2. By Application

        10.6.3. By End-user

        10.6.4. By Country

11. Europe Photodynamic Therapy Market Analysis and Forecast 

    11.1. Introduction

    11.2. Europe Photodynamic Therapy Market Value Forecast, by Product, 2017–2027

        11.2.1. Drugs

            11.2.1.1. Porphyrin Derivative (PD)

                11.2.1.1.1. Hematoporphyrin Derivative (HpD)

                11.2.1.1.2. Benzoporphyrin Derivative (BPD)

                11.2.1.1.3. Texaphyrins 

                11.2.1.1.4. Others

            11.2.1.2. Aminolevulinic Acid (ALA)

            11.2.1.3. Chlorines

            11.2.1.4. Others

        11.2.2. Devices

            11.2.2.1. Disposable Fiber Optic Light Delivery Devices (DFOLDD)

            11.2.2.2. Diode Laser 

    11.3. Europe Photodynamic Therapy Market Value Forecast, by Application, 2017–2027

        11.3.1. Cancer

            11.3.1.1. Basal Cell Carcinoma

            11.3.1.2. Non-small Cell Lung Cancer

            11.3.1.3. Head & Neck Cancer

            11.3.1.4. Others

        11.3.2. Actinic Keratosis (AK)

        11.3.3. Psoriasis

        11.3.4. Acne

        11.3.5. Others

    11.4. Europe Photodynamic Therapy Market Value Forecast, by End-user, 2017–2027

        11.4.1. Hospitals

        11.4.2. Cosmetics & Dermatology Clinics

        11.4.3. Cancer Treatment Centers

        11.4.4. Others 

    11.5. Europe Photodynamic Therapy Market Value Forecast, by Country/Sub-region, 2017–2027

        11.5.1. Germany

        11.5.2. U.K.

        11.5.3. France

        11.5.4. Spain

        11.5.5. Italy 

        11.5.6. Rest of Europe

    11.6. Europe Photodynamic Therapy Market Attractiveness Analysis

        11.6.1. By Product

        11.6.2. By Application 

        11.6.3. By End-user

        11.6.4. By Country/Sub-region

12. Asia Pacific Photodynamic Therapy Market Analysis and Forecast 

    12.1. Introduction

    12.2. Asia Pacific Photodynamic Therapy Market Value Forecast, by Product, 2017–2027

        12.2.1. Drugs

            12.2.1.1. Porphyrin Derivative (PD)

                12.2.1.1.1. Hematoporphyrin Derivative (HpD)

                12.2.1.1.2. Benzoporphyrin Derivative (BPD)

                12.2.1.1.3. Texaphyrins 

                12.2.1.1.4. Others

            12.2.1.2. Aminolevulinic Acid (ALA)

            12.2.1.3. Chlorines

            12.2.1.4. Others

        12.2.2. Devices

            12.2.2.1. Disposable Fiber Optic Light Delivery Devices (DFOLDD)

            12.2.2.2. Diode Laser 

    12.3. Asia Pacific Photodynamic Therapy Market Value Forecast, by Application, 2017–2027

        12.3.1. Cancer

            12.3.1.1. Basal Cell Carcinoma

            12.3.1.2. Non-small Cell Lung Cancer

            12.3.1.3. Head & Neck Cancer

            12.3.1.4. Others

        12.3.2. Actinic Keratosis (AK)

        12.3.3. Psoriasis

        12.3.4. Acne

        12.3.5. Others

    12.4. Asia Pacific Photodynamic Therapy Market Value Forecast, by End-user, 2017–2027

        12.4.1. Hospitals

        12.4.2. Cosmetics & Dermatology Clinics

        12.4.3. Cancer Treatment Centers

        12.4.4. Others 

    12.5. Asia Pacific Photodynamic Therapy Market Value Forecast, by Country/Sub-region, 2017–2027

        12.5.1. Japan

        12.5.2. China

        12.5.3. India

        12.5.4. Australia & New Zealand

        12.5.5. Rest of Asia Pacific

    12.6. Asia Pacific Photodynamic Therapy Market Attractiveness Analysis

        12.6.1. By Product

        12.6.2. By Application 

        12.6.3. By End-user

        12.6.4. By Country/Sub-region

13. Latin America Photodynamic Therapy Market Analysis and Forecast 

    13.1. Introduction

    13.2. Latin America Photodynamic Therapy Market Value Forecast, by Product, 2017–2027

        13.2.1. Drugs

            13.2.1.1. Porphyrin Derivative (PD)

                13.2.1.1.1. Hematoporphyrin Derivative (HpD)

                13.2.1.1.2. Benzoporphyrin Derivative (BPD)

                13.2.1.1.3. Texaphyrins 

                13.2.1.1.4. Others

            13.2.1.2. Aminolevulinic Acid (ALA)

            13.2.1.3. Chlorines

            13.2.1.4. Others

        13.2.2. Devices

            13.2.2.1. Disposable Fiber Optic Light Delivery Devices (DFOLDD)

            13.2.2.2. Diode Laser 

    13.3. Latin America Photodynamic Therapy Market Value Forecast, by Application, 2017–2027

        13.3.1. Cancer

            13.3.1.1. Basal Cell Carcinoma

            13.3.1.2. Non-small Cell Lung Cancer

            13.3.1.3. Head & Neck Cancer

            13.3.1.4. Others

        13.3.2. Actinic Keratosis (AK)

        13.3.3. Psoriasis

        13.3.4. Acne

        13.3.5. Others

    13.4. Latin America Photodynamic Therapy Market Value Forecast, by End-user, 2017–2027

        13.4.1. Hospitals

        13.4.2. Cosmetics & Dermatology Clinics

        13.4.3. Cancer Treatment Centers

        13.4.4. Others 

    13.5. Latin America Photodynamic Therapy Market Value Forecast, by Country/Sub-region, 2017–2027

        13.5.1. Brazil

        13.5.2. Mexico

        13.5.3. Rest of Latin America

    13.6. Latin America Photodynamic Therapy Market Attractiveness Analysis

        13.6.1. By Product

        13.6.2. By Application 

        13.6.3. By End-user

        13.6.4. By Country/Sub-region

14. Middle East & Africa Photodynamic Therapy Market Analysis and Forecast 

    14.1. Introduction

    14.2. Middle East & Africa Photodynamic Therapy Market Value Forecast, by Product, 2017–2027

        14.2.1. Drugs

            14.2.1.1. Porphyrin Derivative (PD)

                14.2.1.1.1. Hematoporphyrin Derivative (HpD)

                14.2.1.1.2. Benzoporphyrin Derivative (BPD)

                14.2.1.1.3. Texaphyrins 

                14.2.1.1.4. Others

            14.2.1.2. Aminolevulinic Acid (ALA)

            14.2.1.3. Chlorines

            14.2.1.4. Others

        14.2.2. Devices

            14.2.2.1. Disposable Fiber Optic Light Delivery Devices (DFOLDD)

            14.2.2.2. Diode Laser 

    14.3. Middle East & Africa Photodynamic Therapy Market Value Forecast, by Application, 2017–2027

        14.3.1. Cancer

            14.3.1.1. Basal Cell Carcinoma

            14.3.1.2. Non-small Cell Lung Cancer

            14.3.1.3. Head & Neck Cancer

            14.3.1.4. Others

        14.3.2. Actinic Keratosis (AK)

        14.3.3. Psoriasis

        14.3.4. Acne

        14.3.5. Others

    14.4. Middle East & Africa Photodynamic Therapy Market Value Forecast, by End-user, 2017–2027

        14.4.1. Hospitals

        14.4.2. Cosmetics & Dermatology Clinics

        14.4.3. Cancer Treatment Centers

        14.4.4. Others 

    14.5. Middle East & Africa Photodynamic Therapy Market Value Forecast, by Country/Sub-region, 2017–2027

        14.5.1. GCC Countries

        14.5.2. South Africa

        14.5.3. Rest of Middle East & Africa

    14.6. Middle East & Africa Photodynamic Therapy Market Attractiveness Analysis

        14.6.1. By Product

        14.6.2. By Application 

        14.6.3. By End-user

        14.6.4. By Country/Sub-region

15. Competition Landscape

    15.1. Global Photodynamic Therapy Market Share Analysis, by Company (2018)

    15.2. Company Profiles

        15.2.1. Biofrontera AG

            15.2.1.1. Company Description

            15.2.1.2. Business Overview

            15.2.1.3. Financial Overview

            15.2.1.4. Strategic Overview

            15.2.1.5. SWOT Analysis

        15.2.2. Theralase Technologies Inc.

            15.2.2.1. Company Description

            15.2.2.2. Business Overview

            15.2.2.3. Financial Overview

            15.2.2.4. Strategic Overview

            15.2.2.5. SWOT Analysis

        15.2.3. LUMIBIRD

            15.2.3.1. Company Description

            15.2.3.2. Business Overview

            15.2.3.3. SWOT Analysis

        15.2.4. Quest PharmaTech Inc.

            15.2.4.1. Company Description

            15.2.4.2. Business Overview

            15.2.4.3. Financial Overview

            15.2.4.4. Strategic Overview

            15.2.4.5. SWOT Analysis

        15.2.5. Modulight, Inc.

            15.2.5.1. Company Description

            15.2.5.2. Business Overview

            15.2.5.3. Strategic Overview

            15.2.5.4. SWOT Analysis

        15.2.6. Galderma Laboratories L.P. (Nestlé)

            15.2.6.1. Company Description

            15.2.6.2. Business Overview

            15.2.6.3. Financial Overview

            15.2.6.4. Strategic Overview

            15.2.6.5. SWOT Analysis

        15.2.7. Sun Pharmaceutical Industries Ltd.

            15.2.7.1. Company Description

            15.2.7.2. Business Overview

            15.2.7.3. Financial Overview

            15.2.7.4. Strategic Overview

            15.2.7.5. SWOT Analysis

        15.2.8. SUS Advancing Technology Co., Ltd

            15.2.8.1. Company Description

            15.2.8.2. Business Overview

            15.2.8.3. SWOT Analysis

List of Tables

Table 01: Global Photodynamic Therapy Market Value (US$ Mn) Forecast, by Product, 2017–2027

Table 02: Global Photodynamic Therapy Market Value (US$ Mn) Forecast, by Drugs, 2017–2027

Table 03: Global Photodynamic Therapy Market Value (US$ Mn) Forecast, by Porphyrin Derivative (PD), 2017–2027

Table 04: Global Photodynamic Therapy Market Value (US$ Mn) Forecast, by Devices, 2017–2027

Table 05: Global Photodynamic Therapy Market Value (US$ Mn) Forecast, by Application, 2017–2027

Table 06: Global Photodynamic Therapy Market Value (US$ Mn) Forecast, by Cancer, 2017–2027

Table 07: Global Photodynamic Therapy Market Value (US$ Mn) Forecast, by End-user, 2017–2027

Table 08: Global Photodynamic Therapy Market Value (US$ Mn) Forecast, by Region, 2017–2027

Table 09: North America Photodynamic Therapy Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

Table 10: North America Photodynamic Therapy Market Value (US$ Mn) Forecast, by Product, 2017–2027

Table 11: North America Photodynamic Therapy Market Value (US$ Mn) Forecast, by Drugs, 2017–2027

Table 12: North America Photodynamic Therapy Market Value (US$ Mn) Forecast, by Porphyrin Derivative (PD), 2017–2027

Table 13: North America Photodynamic Therapy Market Value (US$ Mn) Forecast, by Devices, 2017–2027

Table 14: North America Photodynamic Therapy Market Value (US$ Mn) Forecast, by Application, 2017–2027

Table 15: North America Photodynamic Therapy Market Value (US$ Mn) Forecast, by Cancer, 2017–2027

Table 16: North America Photodynamic Therapy Market Value (US$ Mn) Forecast, by End-user, 2017–2027

Table 17: Europe Photodynamic Therapy Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

Table 18: Europe Photodynamic Therapy Market Value (US$ Mn) Forecast, by Product, 2017–2027

Table 19: Europe Photodynamic Therapy Market Value (US$ Mn) Forecast, by Drug, 2017–2027

Table 20: Europe Photodynamic Therapy Market Value (US$ Mn) Forecast, by Porphyrin Derivative (PD), 2017–2027

Table 21: Europe Photodynamic Therapy Market Value (US$ Mn) Forecast, by Devices, 2017–2027

Table 22: Europe Photodynamic Therapy Market Value (US$ Mn) Forecast, by Application, 2017–2027

Table 23: Europe Photodynamic Therapy Market Value (US$ Mn) Forecast, by Cancer, 2017–2027

Table 24: Europe Photodynamic Therapy Market Value (US$ Mn) Forecast, by End-user, 2017–2027

Table 25: Asia Pacific Photodynamic Therapy Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

Table 26: Asia Pacific Photodynamic Therapy Market Value (US$ Mn) Forecast, by Product, 2017–2027

Table 27: Asia Pacific Photodynamic Therapy Market Value (US$ Mn) Forecast, by Drugs, 2017–2027

Table 28: Asia Pacific Photodynamic Therapy Market Value (US$ Mn) Forecast, by Porphyrin Derivative (PD), 2017–2027

Table 29: Asia Pacific Photodynamic Therapy Market Value (US$ Mn) Forecast, by Devices, 2017–2027

Table 30: Asia Pacific Photodynamic Therapy Market Value (US$ Mn) Forecast, by Application, 2017–2027

Table 31: Asia Pacific Photodynamic Therapy Market Value (US$ Mn) Forecast, by Cancer, 2017–2027

Table 32: Asia Pacific Photodynamic Therapy Market Value (US$ Mn) Forecast, by End-user, 2017–2027

Table 33: Latin America Photodynamic Therapy Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

Table 34: Latin America Photodynamic Therapy Market Value (US$ Mn) Forecast, by Product, 2017–2027

Table 35: Latin America Photodynamic Therapy Market Value (US$ Mn) Forecast, by Drugs, 2017–2027

Table 36: Latin America Photodynamic Therapy Market Value (US$ Mn) Forecast, by Porphyrin Derivative (PD), 2017–2027

Table 37: Latin America Photodynamic Therapy Market Value (US$ Mn) Forecast, by Devices, 2017–2027

Table 38: Latin America Photodynamic Therapy Market Value (US$ Mn) Forecast, by Application, 2017–2027

Table 39: Latin America Photodynamic Therapy Market Value (US$ Mn) Forecast, by Cancer, 2017–2027

Table 40: Latin America Photodynamic Therapy Market Value (US$ Mn) Forecast, by End-user, 2017–2027

Table 41: Middle East & Africa Photodynamic Therapy Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

Table 42: Middle East & Africa Photodynamic Therapy Market Value (US$ Mn) Forecast, by Product, 2017–2027

Table 43: Middle East & Africa Photodynamic Therapy Market Value (US$ Mn) Forecast, by Drugs, 2017–2027

Table 44: Middle East & Africa Photodynamic Therapy Market Value (US$ Mn) Forecast, by Porphyrin Derivative (PD), 2017–2027

Table 45: Middle East & Africa Photodynamic Therapy Market Value (US$ Mn) Forecast, by Devices, 2017–2027

Table 46: Middle East & Africa Photodynamic Therapy Market Value (US$ Mn) Forecast, by Application, 2017–2027

Table 47: Middle East & Africa Photodynamic Therapy Market Value (US$ Mn) Forecast, by Cancer, 2017–2027

Table 48: Middle East & Africa Photodynamic Therapy Market Value (US$ Mn) Forecast, by End-user, 2017–2027

List of Figures

Figure 01: Global Photodynamic Therapy Market Value (US$ Mn) Forecast, 2017–2027

Figure 02: Global Photodynamic Therapy Market Value Share (%), by Product, 2018

Figure 03: Global Photodynamic Therapy Market Value Share (%), by Drugs, 2018

Figure 04: Global Photodynamic Therapy Market Value Share (%), by Application, 2018

Figure 05: Global Photodynamic Therapy Market Value Share (%), by Region, 2018

Figure 06: Global Photodynamic Therapy Market Value Share (%), by Product, 2018 and 2027

Figure 07: Global Photodynamic Therapy Market Value Share (%), by Drugs, 2018 and 2027

Figure 08: Global Photodynamic Therapy Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Drugs, 2017–2027

Figure 09: Global Photodynamic Therapy Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Devices, 2017–2027

Figure 10: Global Photodynamic Therapy Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Porphyrin Derivative (PD), 2017–2027

Figure 11: Global Photodynamic Therapy Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Aminolevulinic Acid (ALA), 2017–2027

Figure 12: Global Photodynamic Therapy Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Chlorines, 2017–2027

Figure 13: Global Photodynamic Therapy Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2017–2027

Figure 14: Global Photodynamic Therapy Market Revenue (US$ Mn) and Y-o-Y Growth (%), by DFOLDD, 2017–2027

Figure 15: Global Photodynamic Therapy Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Diode Laser, 2017–2027

Figure 16: Global Photodynamic Therapy Market Attractiveness, by Product, 2019–2027

Figure 17: Global Photodynamic Therapy Market Attractiveness, by Drugs, 2019–2027

Figure 18: Global Photodynamic Therapy Market Attractiveness, by Devices, 2019–2027

Figure 19: Global Photodynamic Therapy Market Value Share (%), by Application, 2018 and 2027

Figure 20: Global Photodynamic Therapy Market Attractiveness, by Application, 2019–2027

Figure 21: Global Photodynamic Therapy Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Cancer, 2017–2027

Figure 22: Global Photodynamic Therapy Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Actinic Keratosis (AK), 2017–2027

Figure 23: Global Photodynamic Therapy Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Psoriasis, 2017–2027

Figure 24: Global Photodynamic Therapy Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Acne, 2017–2027

Figure 25: Global Photodynamic Therapy Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2017–2027

Figure 26: Global Photodynamic Therapy Market Value Share (%), by End-user, 2018 and 2027

Figure 27: Global Photodynamic Therapy Market Attractiveness Analysis, by End-user

Figure 28: Global Photodynamic Therapy Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Hospitals, 2017–2027

Figure 29: Global Photodynamic Therapy Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Cosmetics & Dermatology Clinics, 2017–2027

Figure 30: Global Photodynamic Therapy Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Cancer Treatment Centers, 2017–2027

Figure 31: Global Photodynamic Therapy Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2017–2027

Figure 32: Global Photodynamic Therapy Market Value Share Analysis, by Region, 2018 and 2027

Figure 33: Global Photodynamic Therapy Market Attractiveness Analysis, by Region, 2019-2027

Figure 34: North America Photodynamic Therapy Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027

Figure 35: North America Photodynamic Therapy Market Value Share (%), by Country/Sub-region, 2018 and 2027

Figure 36: North America Photodynamic Therapy Market Attractiveness, by Country/Sub-region, 2019–2027

Figure 37: North America Photodynamic Therapy Market Value Share, by Product, 2018 and 2027

Figure 38: North America Photodynamic Therapy Market Attractiveness Analysis, by Product, 2019–2027

Figure 39: North America Photodynamic Therapy Market Value Share, by Application, 2018 and 2027

Figure 40: North America Photodynamic Therapy Market Attractiveness Analysis, by Application, 2019–2027

Figure 41: North America Photodynamic Therapy Market Value Share, by End-user, 2018 and 2027

Figure 42: North America Photodynamic Therapy Market Attractiveness Analysis, by End-user, 2019–2027

Figure 43: Europe Photodynamic Therapy Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2027

Figure 44: Europe Photodynamic Therapy Market Value Share (%), by Country/Sub-region, 2018 and 2027

Figure 45: Europe Photodynamic Therapy Market Attractiveness, by Country/Sub-region, 2019–2027

Figure 46: Europe Photodynamic Therapy Market Value Share, by Product, 2018 and 2027

Figure 47: Europe Photodynamic Therapy Market Attractiveness Analysis, by Product, 2019–2027

Figure 48: Europe Photodynamic Therapy Market Value Share, by Application, 2018 and 2027

Figure 49: Europe Photodynamic Therapy Market Attractiveness Analysis, by Application, 2019–2027

Figure 50: Europe Photodynamic Therapy Market Value Share, by End-user, 2018 and 2027

Figure 51: Europe Photodynamic Therapy Market Attractiveness Analysis, by End-user, 2019–2027

Figure 52: Asia Pacific Photodynamic Therapy Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027

Figure 53: Asia Pacific Photodynamic Therapy Market Value Share (%), by Country/Sub-region, 2018 and 2027

Figure 54: Asia Pacific Photodynamic Therapy Market Attractiveness, by Country/Sub-region, 2019–2027

Figure 55: Asia Pacific Photodynamic Therapy Market Value Share, by Product, 2018 and 2027

Figure 56: Asia Pacific Photodynamic Therapy Market Attractiveness Analysis, by Product, 2019–2027

Figure 57: Asia Pacific Photodynamic Therapy Market Value Share, by Application, 2018 and 2027

Figure 58: Asia Pacific Photodynamic Therapy Market Attractiveness Analysis, by Application, 2019–2027

Figure 59: Asia Pacific Photodynamic Therapy Market Value Share, by End-user, 2018 and 2027

Figure 60: Asia Pacific Photodynamic Therapy Market Attractiveness Analysis, by End-user, 2019–2027

Figure 61: Latin America Photodynamic Therapy Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2027

Figure 62: Latin America Photodynamic Therapy Market Value Share (%), by Country/Sub-region, 2018 and 2027

Figure 63: Latin America Photodynamic Therapy Market Attractiveness, by Country/Sub-region, 2019–2027

Figure 64: Latin America Photodynamic Therapy Market Value Share, by Product, 2018 and 2027

Figure 65: Latin America Photodynamic Therapy Market Attractiveness Analysis, by Product, 2019–2027

Figure 66: Latin America Photodynamic Therapy Market Value Share, by Application, 2018 and 2027

Figure 67: Latin America Photodynamic Therapy Market Attractiveness Analysis, by Application, 2019–2027

Figure 68: Latin America Photodynamic Therapy Market Value Share, by End-user, 2018 and 2027

Figure 69: Latin America Photodynamic Therapy Market Attractiveness Analysis, by End-user, 2019–2027

Figure 70: Middle East & Africa Photodynamic Therapy Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2027

Figure 71: Middle East & Africa Photodynamic Therapy Market Value Share (%), by Country/Sub-region, 2018 and 2027

Figure 72: Middle East & Africa Photodynamic Therapy Market Attractiveness, by Country/Sub-region, 2019–2027

Figure 73: Middle East & Africa Photodynamic Therapy Market Value Share, by Product, 2018 and 2027

Figure 74: Middle East & Africa Photodynamic Therapy Market Attractiveness Analysis, by Product, 2019–2027

Figure 75: Middle East & Africa Photodynamic Therapy Market Value Share, by Application, 2018 and 2027

Figure 76: Middle East & Africa Photodynamic Therapy Market Attractiveness Analysis, by Application, 2019–2027

Figure 77: Middle East & Africa Photodynamic Therapy Market Value Share, by End-user, 2018 and 2027

Figure 78: Middle East & Africa Photodynamic Therapy Market Attractiveness Analysis, by End-user, 2019–2027

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

Request Customization

Photodynamic Therapy Market